Professor Simon Baron-Cohen, leader of Spectrum 10K and a director of the Autism Research Centre (ARC) has paused the controversial research project after almost three weeks of criticism.
Earlier this week, Baron-Cohen acknowledged for the first time the backlash from the autistic community after Spectrum 10K planned to collect and analyse people’s DNA specimens, which autistic advocates fear will lead to the ‘eradication of autism’.
The autistic community have been wary of research projects like Spectrum 10K and the AIMS-2-TRIALS in recent years, fearing it will lead to a potential ‘autism screening’.
Similar technology already exists for screening unborn babies with Down’s syndrome, where parents are offered the opportunity to abort the pregnancy if it is detected the offspring has the learning disability.
The autistic community fear this will lead to a similar process for screening autism, and that ordinary people ‘playing God’ who should be allowed to be born based on whether they are likely to be contributing to society is a worrying precedent towards eugenics.
Related: James Cuszack says researchers are not getting right on biological research
Speaking on behalf of his Spectrum 10K research team, Baron-Cohen said, “We have decided to pause any further recruitment of new participants into Spectrum 10K.
“We will also not analyse any data already collected in Spectrum 10K. This will give us time to co-design and conduct a meaningful consultation with autistic people and their families and incorporate suggestions for how to improve Spectrum 10K.”
Any review is likely to take several months, but autistic people will be fully included in the process.
Details of a future consultation will be announced on the Spectrum 10K website in due course.
The University of Cambridge, Wellcome Trust, and the Cambridgeshire & Peterborough NHS Foundation Trust, who are supportive of the study have announced their support to the delay of the controversial research project.
